AXICHEM AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.475 SEK | -8.10% |
|
-4.84% | -63.22% |
| Mar. 13 | OmneDiem Launches Two New Products | CI |
| Mar. 05 | AXichem AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
| Sales 2021 | 4.36 47.77 | Sales 2022 | 5.01 54.83 | Capitalization | 229M 2.51B |
|---|---|---|---|---|---|
| Net income 2021 | -15M -164M | Net income 2022 | -17M -186M | EV / Sales 2021 | 91,087,264 x |
| Net cash position 2021 | 9.45M 104M | Net Debt 2022 | 12.21M 134M | EV / Sales 2022 | 48,178,062 x |
| P/E ratio 2021 |
-26.6
x | P/E ratio 2022 |
-13.3
x | Employees | 7 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 87.33% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -8.10% | ||
| 1 week | -4.84% | ||
| Current month | -1.67% | ||
| 1 month | -0.34% | ||
| 3 months | -58.68% | ||
| 6 months | -86.47% | ||
| Current year | -63.22% |
1 week
1.40
1.78
1 month
1.401.78
Current year
1.404.98
1 year
1.4015.50
3 years
1.4036.70
5 years
1.4091.80
10 years
1.4095.80
| Managers | Title | Age | Since |
|---|---|---|---|
| Founder | 67 | 07-07-05 | |
Erik Lager
CTO | Chief Tech/Sci/R&D Officer | 49 | 19-03-31 |
Gunilla Savring
BRD | Director/Board Member | 62 | 13-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Founder | 67 | 07-07-05 | |
| Chairman | 78 | 16-12-31 | |
Gunilla Savring
BRD | Director/Board Member | 62 | 13-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-15 | 1.605 | +3.22% | 24,373 |
| 24-04-12 | 1.555 | +2.30% | 60,507 |
| 24-04-11 | 1.52 | -3.80% | 23,728 |
| 24-04-10 | 1.58 | +1.94% | 37,024 |
| 24-04-09 | 1.55 | -3.13% | 41,934 |
Delayed Quote Nasdaq Stockholm, April 16, 2024 at 11:29 am EDT
More quotes
aXichem AB (publ) is a Sweden-based biochemical company. It develops an eco-friendly solution, Phenylcapsaicin. Phenylcapsaicin is a non-toxic antifouling agent, which can be used in the shipping industry, as it keeps vessels free from fouling. Additionally, the Company holds several world patents for alternative uses and applications of phenylcapsaicin. Phenylcapsaicin can be applied as bio-repellent against all living organisms in settings where animals cause damage to human installations. The Companyâs products comprise bio-repellents, feed ingredients, food and dietary supplements, which contain synthetically produced and patented capsaicin, traded as aXiphen. The Companyâs shareholders are MANAKIN LTD, BLACK ARROW LTD and LMK VENTURES AB, among others.
Sector
Specialty Chemicals
Calendar
2024-05-21
- Q1 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -63.22% | 3.17M | |
| +3.07% | 25.5B | |
| -27.97% | 3.19B | |
| +11.44% | 1.75B | |
| -24.58% | 539M | |
| -27.16% | 380M | |
| -81.65% | 216M | |
| -15.40% | 51.46M |
- Stock Market
- Equities
- AXIC A Stock
